Impact of Multi-component Interventions on Populations with Mental Health Symptoms and High-risk COPD
NCT ID: NCT06458218
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
7400 participants
INTERVENTIONAL
2024-06-17
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Intervention: We have constructed a pay-for-population mechanism for medical practitioners within the intervention townships to encourage them caring for population health. For study participants in the intervention arm, we will ask them to finish an online COPD-SQ questionnaire with notification of his or her COPD high risk status. For those with high-risk COPD population, we will provide face-to-face survey, simple physical examination, pulmonary function tests, and provide a multi-component intervention at baseline. For high-risk COPD population with mental health issues in the intervention arm, we provide community-based spirometry pulmonary function test (PFT) and education; If individuals whose post-bronchodilator FEV1/FVC\<0.7, they will be spirometry-defined COPD patients and will be encouraged to seek treatment and medication to the superior hospitals. A CBT-based digital health intervention program, EmoEase, will be provided to our study participants with an intelligent mobile phone. Also health education in terms of mental health issues will be given. Additionally, we provide (1) a digital health intervention programs to smokers; (2) CBT-based health education for study participants with abnormal BMI; (3) active recruitment into National Essential Public Health Program in China for those with abnormal blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3 (telephone interview), month 6 (face-to-face with full steps of physical examination), and month 12.
Comparison: Those who are assigned in the control arm, we will ask them to finish the same COPD-SQ online questionnaire with notification of his or her COPD high risk status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given.
Outcomes: The primary outcomes are PHQ-9 scores for depression symptoms, GAD-7 symptoms for anxiety symptoms, and WEM-WBS score at month 12.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lifestyle Interventions for Overweight Adults With Mental Illness
NCT04708379
Mobile Health Intervention to Support Healthful Diet
NCT05236712
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial
NCT02453217
Promoting Mental and Cognitive Health in Old Age Through Scalable Evidence-based Interventions
NCT07072338
Healthy Mind Healthy You: A Study of Mindfulness
NCT03844321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm
We have constructed a pay-for-population mechanism to encourage medical workers caring for population health. We will ask study populations to finish online COPD-SQ questionnaire with notification of his or her COPD high risk status. For high-risk COPD population, we will provide a face-to-face survey and examination, and provide a multi-component intervention at baseline. We give community-based spirometry pulmonary function test and education; If individuals who are COPD patients, they will be encouraged to seek treatment to the superior hospitals. A CBT-based digital health program will be provided. Also health education will be given. Additionally, we provide (1) a digital health intervention programs to smokers; (2) CBT-based health education for the abnormal BMI; (3) active recruitment into National Essential Public Health Program for those with high blood pressure and blood glucose. Intensive follow-ups will be conducted at month 3, 6, 12.
Multi-component Interventions
1. Community-based spirometry pulmonary function tests and result interpretations and health education for COPD;
2. A digital health intervention program, EmoEase, for individuals with mental health issues among high-risk COPD population(very familiar with intelligent mobile phone);
3. NicQuit, digital health intervention to smokers;
4. Health education to smokers and individuals with mental health issues;
5. Encouragement to seek professional medication treatment in superior hospitals for spirometry-defined COPD patients;
6. To actively include individuals whose blood pressure and glucose are higher than the normal value into the National Essential Public Health Service in China;
7. A CBT-based health education to the BMI abnormal;
8. Pay-for-performance incentives to medical workers.
Control Arm
Those who are assigned in the control arm, we will ask them to finish the same COPD-SQ online questionnaire with notification of his or her COPD high risk status and a face-to-face survey. No physical examinations, community-based pulmonary function tests will be given.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multi-component Interventions
1. Community-based spirometry pulmonary function tests and result interpretations and health education for COPD;
2. A digital health intervention program, EmoEase, for individuals with mental health issues among high-risk COPD population(very familiar with intelligent mobile phone);
3. NicQuit, digital health intervention to smokers;
4. Health education to smokers and individuals with mental health issues;
5. Encouragement to seek professional medication treatment in superior hospitals for spirometry-defined COPD patients;
6. To actively include individuals whose blood pressure and glucose are higher than the normal value into the National Essential Public Health Service in China;
7. A CBT-based health education to the BMI abnormal;
8. Pay-for-performance incentives to medical workers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High-risk COPD population, defined by score of COPD-SQ ≥ 16;
* Mental health issues, defined by WEM-WBS scale \< 45;
* Local residents who stay within a township in the previous 3 months and plan to stay within the same township for the next 12 months.
Exclusion Criteria
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China-Japan Friendship Hospital
OTHER
Peking Union Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simiao Chen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simiao Chen, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xishui County
Zunyi, Guizhou, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAMS&PUMC-IEC-2024-043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.